Outset Medical OM
NASDAQ OM
$4.28 -0.02 (-0.35%)
As of: Aug 20, 2026 · 3:59 PM EDT

Outset Medical (OM) Gains from Investment Securities (2025)

Outset Medical (OM) posted quarterly Gains from Investment Securities of $4.4 million for Q1 2025.

Outset Medical (OM) Gains from Investment Securities (2025) Analysis & Trends

Outset Medical (OM) has reported Gains from Investment Securities for 1 consecutive years, with $4.4 million the latest figure, recorded in Q1 2025.

  • In Q1 2025, Gains from Investment Securities changed N/A year-over-year to $4.4 million; the TTM figure through Dec 2025 stood at $4.4 million (changed N/A YoY), while the FY2025 annual figure was $4.4 million, changed N/A from the prior year.
  • Gains from Investment Securities held at $4.4 million in Q1 2025 per OM's latest filing.
  • Across five years, Gains from Investment Securities topped out at $4.4 million in Q1 2025 and bottomed at $4.4 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Outset Medical 80.25 Mn -182.94 Mn 13.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2025 4.37 Mn
Mar 31, 2025 4.37 Mn